SHE:301096 - Hangzhou Bio-Sincerity Pharma-Tech Co Ltd Hangzhou Bio-Sincerity Pharma-
Sector: Health Care, Industry: Pharmaceuticals
Add to Watchlist
   
Add Alert 


Yahoo Finance
Balance Sheet Cash Flow Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
2017 Q4 2018 Q4 2019 Q3 2019 Q4 2020 Q1 2020 Q2 2020 Q3 2020 Q4 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 Graph
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 267.38M
17.2%
304.24M
13.8%
374.31M
23.0%
425.4M
13.6%
478.72M
12.5%
572.75M
19.6%
607.41M
6.1%
672.53M
10.7%
785.6M
16.8%
900.47M
14.6%
1.02B
13.0%
1.07B
5.4%
Cost of Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 87.83M
331.3%
96.65M
10.0%
122.53M
26.8%
133.82M
9.2%
159.97M
19.5%
177.17M
10.8%
198.18M
11.9%
221.73M
11.9%
255.38M
15.2%
304.24M
19.1%
350.74M
15.3%
364.14M
3.8%
Gross Profit [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 179.55M
14.2%
207.59M
15.6%
251.78M
21.3%
291.59M
15.8%
318.75M
9.3%
395.58M
24.1%
409.23M
3.5%
450.79M
10.2%
530.23M
17.6%
596.23M
12.4%
666.71M
11.8%
708.09M
6.2%
Total Expenses [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 168.68M
316.3%
187.67M
11.3%
249.19M
32.8%
294.37M
18.1%
337.04M
14.5%
400.69M
18.9%
446.57M
11.4%
492.28M
10.2%
563.65M
14.5%
642.6M
14.0%
719.54M
12.0%
752.77M
4.6%
Operating Expense [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 80.85M
301.1%
91.01M
12.6%
126.66M
39.2%
160.56M
26.8%
177.07M
10.3%
223.52M
26.2%
248.39M
11.1%
270.54M
8.9%
308.27M
13.9%
338.36M
9.8%
368.8M
9.0%
388.62M
5.4%
Operating Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 98.69M
13.8%
116.57M
18.1%
125.12M
7.3%
131.03M
4.7%
141.68M
8.1%
172.06M
21.4%
160.84M
-6.5%
180.25M
12.1%
221.96M
23.1%
257.88M
16.2%
297.91M
15.5%
319.46M
7.2%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 84.79M
-
- 110.97M
-
- 155.03M
-
- 194.04M
-
- 228.59M
-
- 272.01M
-
-
Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 84.93M
30.8%
101.03M
19.0%
111.09M
10.0%
126.3M
13.7%
155.16M
22.8%
191.79M
23.6%
194.16M
1.2%
209.7M
8.0%
228.6M
9.0%
250.43M
9.5%
271.97M
8.6%
286.72M
5.4%
Basic EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.04
29.6%
1.25
20.2%
1.37
9.6%
1.5
9.5%
1.66
10.7%
1.91
15.1%
1.8
-5.8%
1.94
7.8%
2.11
8.8%
2.32
10.0%
2.51
8.2%
2.65
5.6%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.04
29.6%
1.25
20.2%
1.37
9.6%
1.5
9.5%
1.66
10.7%
1.91
15.1%
1.79
-6.3%
1.93
7.8%
2.1
8.8%
2.31
10.0%
2.51
8.7%
2.65
5.6%
Values are in CNY whenever applicable | Fiscal year ends on December 31
Powered by Morningstar

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms